Oncology

Finance, Investing, Stocks

CG Oncology: What You Need to Know About the Potential Game-Changing Top-Line Data Coming in 2024!

BY
Carl Nightbridge

Boston, MA – CG Oncology, a biotechnology company, is gaining attention as they prepare for the American Society of Clinical ...

Finance, Investing, Stocks

Oncology Innovation: How Corbus Pharmaceuticals CRBP Stock Could Revolutionize Cancer Treatment

BY
Carl Nightbridge

NORWOOD, MASSACHUSETTS – Investing in biotech stocks can be both thrilling and risky, particularly when it comes to companies like ...

Finance, Investing, Stocks

PYX Oncology Updates: Promising Progress on Antibodies and ADCs – What Investors Need to Know Now

BY
Carl Nightbridge

Cambridge, MA – Pyxis Oncology, a biotechnology company based in Cambridge, Massachusetts, is making strides in developing antibodies and antibody-drug ...

Finance, Investing, Stocks

Zymeworks Breakthrough: Zanidatamab’s Game-Changing Potential Unveiled in Oncology

BY
Carl Nightbridge

Vancouver, Canada – Zymeworks, a biopharmaceutical company based in Vancouver, has seen a significant 67% increase in its stock value ...

Finance, Investing, Stocks

Radiopharmaceuticals Innovator Fusion Pharmaceuticals Carving Out a Niche in Oncology – Here’s Why Investors Are Watching

BY
Carl Nightbridge

Cambridge, Massachusetts — Fusion Pharmaceuticals, a company based in Cambridge, Massachusetts, is making strides in the field of oncology, specifically ...

Breaking News

Predictive Oncology Inc. (NASDAQ:POAI) Q3 2023 Earnings Conference Call Reveals Groundbreaking Cancer Research Collaboration Results – Find Out What They Discovered!

BY
Carl Nightbridge

Predictive Oncology Inc. (NASDAQ:POAI) held its Q3 2023 Earnings Conference Call on November 14, 2023, at 8:30 AM ET. The ...

Breaking News

Bristol-Myers Squibb Makes $5.8 Billion Acquisition to Expand its Oncology Portfolio

BY
Carl Nightbridge

NEW YORK (AP) — Bristol-Myers Squibb announced on Sunday its plans to acquire cancer drugmaker Mirati Therapeutics for up to ...

Breaking News

New AI Tool, CHARM, Rapidly Identifies Brain Tumor Molecular Identity During Surgery – Potential for Real-Time Precision Oncology

BY
Carl Nightbridge

Scientists at Harvard Medical School have developed an artificial intelligence (AI) tool, called CHARM, that can quickly decode a brain ...